Trial · NCT02048371
Results by group31
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 31
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-free Survival (PFS). Cohort A and Cohort B | Cohort A: Liposarcoma | 1.87 | 95% Confidence Interval 0.92 to 3.67 | months | |
| Progression-free Survival (PFS). Cohort A and Cohort B | Cohort A: Liposarcoma, Placebo | 2.07 | 95% Confidence Interval 1.64 to 3.44 | months | |
| Progression-free Survival (PFS). Cohort A and Cohort B | Cohort B: Osteosarcoma | 3.6 | 95% Confidence Interval 2.0 to 7.6 | months | |
| Progression-free Survival (PFS). Cohort A and Cohort B | Cohort B: Osteosarcoma, Placebo | 1.7 | 95% Confidence Interval 1.2 to 1.8 | months | |
| Progression-free Survival (PFS). Cohort C, Cohort D, and Cohort E | Cohort C: Ewing Sarcoma | 3.4 | 95% Confidence Interval 1.7 to 3.7 | months | |
| Progression-free Survival (PFS). Cohort C, Cohort D, and Cohort E | Cohort D: Rhabdomyosarcoma | 1.82 | 95% Confidence Interval 1.58 to NA | months | |
| Progression-free Survival (PFS). Cohort C, Cohort D, and Cohort E | Cohort E: Mesenchymal Chondrosarcoma | NA | 95% Confidence Interval NA to NA | months | |
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort A: Liposarcoma | 12 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort A: Liposarcoma, Placebo | 15 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort B: Osteosarcoma | 6 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort B: Osteosarcoma, Placebo | 9 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort C: Ewing Sarcoma | 6 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort D: Rhabdomyosarcoma | 2 | Participants | ||
| The Number of Participants With Reported CTCAE (Common Terminology Criteria for Adverse Events) Version 4.03 Adverse Events. All Cohorts. | Cohort E: Mesenchymal Chondrosarcoma | 0 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort A: Liposarcoma | 0 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort A: Liposarcoma, Placebo | 1 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort B: Osteosarcoma | 3 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort B: Osteosarcoma, Placebo | 0 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort C: Ewing Sarcoma | 3 | Participants | ||
| Overall Response Rate (ORR). All Cohorts. | Cohort D: Rhabdomyosarcoma | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02048371/results